Shares of T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) passed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.0004. T2 Biosystems shares last traded at $0.0030, with a volume of 666 shares trading hands.
T2 Biosystems Price Performance
The company has a market cap of $63,129.00, a PE ratio of 0.00 and a beta of 8.21.
About T2 Biosystems
T2 Biosystems, Inc is a commercial‐stage diagnostics company focused on developing and marketing innovative, rapid diagnostic products designed to improve patient outcomes and reduce healthcare costs. The company’s proprietary T2 Magnetic Resonance (T2MR) technology enables direct detection of pathogens and biomarkers in whole blood without the need for culture, delivering results in hours rather than days. T2 Biosystems’ core mission is to provide clinicians with faster, actionable data to guide treatment decisions, particularly in the management of sepsis, bloodstream infections and other life‐threatening conditions.
The flagship product, the T2Dx® Instrument, serves as the platform for all T2 assays.
Recommended Stories
- Five stocks we like better than T2 Biosystems
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
- 3 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPO
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
